# Corcept Therapeutics Inc: Form 8-K, filed Aug 2, 2023

- Company: [Corcept Therapeutics Inc](/companies/cort.md) (CIK 1088856)
- Form: 8-K
- Filed: 2023-08-02
- Accepted by EDGAR: Aug 2, 2023, 16:09 ET
- Period: 2023-08-02
- Accession: 0001628280-23-026757
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1088856/000162828023026757/cort-20230802.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1088856/000162828023026757/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1088856/000162828023026757/cort-20230802.htm

Filed Aug 2, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-026757. Last ingested by Listed: Oct 27, 2026, 17:31 ET. No prices; not investment advice.